Home

Versant Venture Capital II, LP

CIK 1354131 · last filed 2014-11-12

Versant Venture Capital II, LP is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider sold $1.7M of INGN on Nov 12, 2014. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $72.4K across reported positions. The firm reports its address in San Francisco, CA. 45 SEC filings were submitted jointly with Versant Affiliates Fund II-A, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$72.4K

Companies

3

Total Filings

5

Lifetime Open-Market Net

-$3.15M

Filer Profile

Reported Address
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA 94104
Phone
(650) 233-7877
State of Incorporation
DE
Related Filers
Versant Affiliates Fund II-A, LP — 45 joint filings, latest 2015-05-11
Versant Side Fund II, LP — 45 joint filings, latest 2015-05-11
Versant Ventures II LLC — 43 joint filings, latest 2015-05-11
REBECCA B ROBERTSON — 30 joint filings, latest 2015-05-11
ROSS A MD JAFFE — 24 joint filings, latest 2015-05-11
BRIAN G ATWOOD — 20 joint filings, latest 2015-05-11
SAMUEL D COLELLA — 20 joint filings, latest 2015-05-11
WILLIAM J PHD LINK — 20 joint filings, latest 2015-05-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INGN 10%+ Owner 13,640 $5.31 $72.4K -$3.15M 3 2014-11-12
KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted 10%+ Owner 43,583 — — $0 1 2012-10-16
HELICOS BIOSCIENCES CORP (HLCS) Delisted 10%+ Owner 196,522 — — $0 1 2008-12-29

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-11-12 INGN Sell (S) −69,096 -$1.69M EDGAR
2014-10-09 INGN Mixed −275,240 -$1.45M EDGAR
2014-02-21 INGN Conv (C) +14,998,052 $0 EDGAR
2012-10-16 KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted Mixed +11,925,255 $2.2K EDGAR
2008-12-29 HELICOS BIOSCIENCES CORP (HLCS) Delisted Buy (P) +60,344,830 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.